Cargando…

Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months

BACKGROUND: Although several studies have been conducted on the role of surgery in localized neuroblastoma, the impact of surgical timing and extent of primary tumor resection on outcome in high-risk patients remains controversial. METHODS: Patients from the German neuroblastoma trial NB97 with loca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fischer, Janina, Pohl, Alexandra, Volland, Ruth, Hero, Barbara, Dübbers, Martin, Cernaianu, Grigore, Berthold, Frank, von Schweinitz, Dietrich, Simon, Thorsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543757/ https://www.ncbi.nlm.nih.gov/pubmed/28778185 http://dx.doi.org/10.1186/s12885-017-3493-0

Ejemplares similares

A new risk score for patients after first recurrence of stage 4 neuroblastoma aged ≥18 months at first diagnosis
por: Kreitz, Kiana, et al.
Publicado: (2019)

Genetic Alterations and Resectability Predict Outcome in Patients with Neuroblastoma Assigned to High-Risk Solely by MYCN Amplification
por: Berthold, Frank, et al.
Publicado: (2021)

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project
por: Schleiermacher, G, et al.
Publicado: (2012)

Identification of the Novel Methylated Genes' Signature to Predict Prognosis in INRG High-Risk Neuroblastomas
por: Liu, Zhichao, et al.
Publicado: (2021)

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
por: Ambros, P F, et al.
Publicado: (2009)

Retracted: Identification of the Novel Methylated Genes' Signature to Predict Prognosis in INRG High-Risk Neuroblastomas
por: Osteoporosis, Journal of
Publicado: (2022)

Primary anastomosis as a valid alternative for extremely low birth weight infants with spontaneous intestinal perforation
por: Dübbers, Martin, et al.
Publicado: (2021)

Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force
por: Matthay, K K, et al.
Publicado: (2010)

Retrospective Analysis of INRG Clinical and Genomic Factors for 605 Neuroblastomas in Japan: A Report from the Japan Children’s Cancer Group Neuroblastoma Committee (JCCG-JNBSG) †
por: Ohira, Miki, et al.
Publicado: (2021)

Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment
por: Rosswog, Carolina, et al.
Publicado: (2017)

Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy
por: Simon, Thorsten, et al.
Publicado: (2011)

Excellent treatment outcomes in children younger than 18 months with stage 4 MYCN nonamplified neuroblastoma
por: Kim, Chiwoo, et al.
Publicado: (2018)

Comparing presentations and outcomes of children with cancer: a study between a lower-middle-income country and a high-income country
por: Farrag, Ahmed, et al.
Publicado: (2023)

Treatment and outcome of Ganglioneuroma and Ganglioneuroblastoma intermixed
por: Decarolis, Boris, et al.
Publicado: (2016)

FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma
por: Ackermann, Sandra, et al.
Publicado: (2014)

Total Psoas Muscle Area as a Marker for Sarcopenia Is Related to Outcome in Children With Neuroblastoma
por: Ritz, Annika, et al.
Publicado: (2021)

Transumbilical cord access (TUCA) for laparoscopy in infants and children: simple, safe and fast
por: Tröbs, Ralf-Bodo, et al.
Publicado: (2015)

Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation
por: Berthold, Frank, et al.
Publicado: (2018)

Correction: Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation
por: Berthold, Frank, et al.
Publicado: (2019)

Cases of low anterior resection and ileostomy for rectal cancer that required more than 18 months for stoma closure
por: Kojima, Yutaka, et al.
Publicado: (2019)

Reliable assessment of telomere maintenance mechanisms in neuroblastoma
por: Meeser, Alina, et al.
Publicado: (2022)

Neuroblastoma Screening at 1 Year of Age: The Final Results of a Controlled Trial
por: Berthold, Frank, et al.
Publicado: (2021)

The role of complex genomic alterations in neuroblastoma risk estimation
por: Fischer, Matthias, et al.
Publicado: (2010)

Genomic ALK alterations in primary and relapsed neuroblastoma
por: Rosswog, Carolina, et al.
Publicado: (2023)

Serum polysialylated neural cell adhesion molecule in childhood neuroblastoma.
por: Glüer, S., et al.
Publicado: (1998)

Co-regulated expression of HAND2 and DEIN by a bidirectional promoter with asymmetrical activity in neuroblastoma
por: Voth, Harald, et al.
Publicado: (2009)

Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma
por: Kocak, H, et al.
Publicado: (2013)

Long-term follow-up of children with neuroblastoma receiving radiotherapy to metastatic lesions within the German Neuroblastoma Trials NB97 and NB 2004
por: Jazmati, Danny, et al.
Publicado: (2020)

MYCN transcriptionally represses CD9 to trigger an invasion-metastasis cascade in neuroblastoma
por: Fabian, Johannes, et al.
Publicado: (2015)

GATA factors in human neuroblastoma: distinctive expression patterns in clinical subtypes
por: Hoene, V, et al.
Publicado: (2009)

Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group
por: De Bernardi, B, et al.
Publicado: (2008)

MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma
por: Fabian, Johannes, et al.
Publicado: (2016)

Pediatric hepatocellular carcinoma: challenges and solutions
por: Schmid, Irene, et al.
Publicado: (2017)

Anti-GD2 Based Immunotherapy Prevents Late Events in High-Risk Neuroblastoma Patients over 18 Months at Diagnosis
por: Tas, Michelle L., et al.
Publicado: (2021)

Segmental chromosomal aberrations as the poor prognostic factor in children over 18 months with stage 3 neuroblastoma without MYCN amplification
por: Wieczorek, Aleksandra, et al.
Publicado: (2023)

Presenting features of neuroblastoma with spinal canal invasion. A prospective study of the International Society of Pediatric Oncology Europe - Neuroblastoma (SIOPEN)
por: Sorrentino, Stefania, et al.
Publicado: (2022)

Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse
por: Flaadt, Tim, et al.
Publicado: (2023)

Systemerkrankungen
por: Burdelski, Martin, et al.
Publicado: (2013)

A comparison of outcomes of bariatric surgery in patient greater than 70 with 18 month of follow up
por: Zaveri, Hinali, et al.
Publicado: (2016)

An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma
por: Formicola, Daniela, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q7pbc4f8rde6olq4or3n00uud2